The semi-annual review of the VINX 30 Index has now been completed. As a result of the review, Genmab (GEN) will be added, whereas A.P. Moller – Maersk B (MAERSK B) will be removed from the index.
The VINX 30 Index constituents effective with the market open on Monday, June 20, 2016 are:
ABB Ltd | Novo Nordisk B |
ASSA ABLOY AB ser. B | Pandora |
AstraZeneca PLC | Sampo Plc A |
Atlas Copco AB ser. A | Sandvik AB |
Carlsberg A/S B | Skand. Enskilda Banken ser. A |
Coloplast B | Statoil ASA |
Danske Bank | Swedbank AB ser A |
DNB ASA | Svenska Cellulosa AB SCA ser. B |
Ericsson, Telefonab. L M ser. B | Svenska Handelsbanken ser. A |
Genmab | Telenor ASA |
Hennes & Mauritz AB, H & M ser. B | Telia Company AB |
Investor AB ser. B | UPM-Kymmene Corporation |
KONE Oyj B | Vestas Wind Systems |
Nokia Corporation | Volvo, AB ser. B |
Nordea Bank AB | Yara International ASA |
For full access to daily data on weights, proforma, free float factors, corporate actions, historical index values etc. please sign up for our Global Index Watch service at http://indexes.nasdaqomx.com/
For further information concerning this notice please contact Nasdaq Global Index Operations, telephone + 46 8 405 62 96, or e-mail indexsupport@nasdaq.com